In any case, California’s decision to ban CBD oil from hemp seems like it may be informed more by legalistic hair-splitting. And to illustrate how finely that hair is split, recall that CBD is a controlled substance under federal law, regardless of what it is derived from. Yet federal policy is also contradictory. The FDA’s recent approval of the CBD medicine Epidiolex comes despite the fact that the DEA considers CBD a Schedule I substance, with no medical applications. A DEA rescheduling or de-scheduling of CBD would go a long way toward resolving these questions — and is coming in the next three months.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.